In today's trading session, Ajanta Pharma experienced a price increase of 2.06%, with the stock price reaching Rs 2,611.90. This movement highlights the stock's activity in the current market environment.
The stock is part of the NIFTY MIDCAP 150 index, reflecting its position among mid-sized companies in the Indian market.
Financial Performance
Analyzing Ajanta Pharma's financial performance over the past year, we can observe trends in revenue, net profit, and EPS (Earnings Per Share). The data presented is on a consolidated basis.
Quarterly Performance:
| Period | Revenue (Cr) | Net Profit (Cr) | EPS |
|---|---|---|---|
| Mar 2024 | Rs 1,054.08 | Rs 202.72 | 16.10 |
| Jun 2024 | Rs 1,144.92 | Rs 245.77 | 19.54 |
| Sep 2024 | Rs 1,186.64 | Rs 216.48 | 17.27 |
| Dec 2024 | Rs 1,146.13 | Rs 232.88 | 18.60 |
| Mar 2025 | Rs 1,170.41 | Rs 225.26 | 18.00 |
| Year | Revenue (Cr) | Net Profit (Cr) | EPS | BVPS | ROE | Debt to Equity |
|---|---|---|---|---|---|---|
| 2021 | Rs 2,889.69 | Rs 653.87 | 75.09 | 344.52 | 21.82 | 0.00 |
| 2022 | Rs 3,340.99 | Rs 712.68 | 82.45 | 380.24 | 21.83 | 0.00 |
| 2023 | Rs 3,742.64 | Rs 587.98 | 45.89 | 268.14 | 17.35 | 0.00 |
| 2024 | Rs 4,208.71 | Rs 816.17 | 64.82 | 282.34 | 22.87 | 0.00 |
| 2025 | Rs 4,648.10 | Rs 920.39 | 73.56 | 302.38 | 24.28 | 0.00 |
Key Financial Metrics (Consolidated)
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|
| Sales (Cr) | 4,648 | 4,208 | 3,742 | 3,340 | 2,889 |
| Other Income (Cr) | 94 | 84 | 98 | 115 | 25 |
| Total Income (Cr) | 4,742 | 4,293 | 3,841 | 3,456 | 2,915 |
| Total Expenditure (Cr) | 3,532 | 3,172 | 3,090 | 2,536 | 2,007 |
| EBIT (Cr) | 1,209 | 1,121 | 751 | 919 | 908 |
| Interest (Cr) | 20 | 7 | 5 | 10 | 8 |
| Tax (Cr) | 268 | 297 | 157 | 196 | 246 |
| Net Profit (Cr) | 920 | 816 | 587 | 712 | 653 |
The company’s financial data indicates steady performance. The most recent annual EPS is Rs 73.56, and the company maintains a zero debt-to-equity ratio, suggesting financial stability.
Based on Moneycontrol analysis as of May 30, 2025, investor sentiment towards Ajanta Pharma is very bearish. With a price increase of 2.06%, Ajanta Pharma reflects activity in today's trading session.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
